BVS vs. LFMD

Last updated Jun 3, 2026

BVS (Bioventus Inc.) and LFMD (LifeMD, Inc.) are both stocks. Both are in the Healthcare sector — BVS in Medical Devices, LFMD in Pharmaceutical Retailers. Over the past 5 years, BVS returned -14.50%/yr vs -19.17%/yr for LFMD. At a 0.22 correlation, their price movements are largely independent.

Performance

BVS vs. LFMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bioventus Inc. (BVS) and LifeMD, Inc. (LFMD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BVS achieves a 9.01% return, which is significantly lower than LFMD's 37.54% return.

BVS

• 1D: 2.27%
• 1M: -19.78%
• YTD: 9.01%
• 6M: 7.28%
• 1Y: 25.93%
• 3Y*: 39.93%
• 5Y*: -14.50%
• 10Y*: —

LFMD

• 1D: 1.30%
• 1M: -6.20%
• YTD: 37.54%
• 6M: 31.74%
• 1Y: -63.50%
• 3Y*: 29.89%
• 5Y*: -19.17%
• 10Y*: 13.19%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BVS vs. LFMD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
BVS Bioventus Inc.	9.01%	-29.14%	99.24%	101.92%	-81.99%	-24.57%
LFMD LifeMD, Inc.	37.54%	-31.11%	-40.29%	327.32%	-49.87%	-85.84%

Correlation

The correlation between BVS and LFMD is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.21
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.24
Correlation (All Time) Calculated using the full available price history since Feb 12, 2021	0.22

Fundamentals

Market Cap BVS : $567.77M LFMD : $222.01M
EPS BVS : $0.41 LFMD : -$0.37
PS Ratio BVS : 0.97 LFMD : 0.99
PB Ratio BVS : 3.01 LFMD : 14.76
Total Revenue (TTM) BVS : $576.30M LFMD : $219.42M
Gross Profit (TTM) BVS : $390.14M LFMD : $190.14M
EBITDA (TTM) BVS : $98.72M LFMD : -$6.29M

Return for Risk

BVS vs. LFMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BVS

BVS Risk / Return Rank: 59
BVS Sharpe Ratio Rank: 58
BVS Sortino Ratio Rank: 56
BVS Omega Ratio Rank: 55
BVS Calmar Ratio Rank: 59
BVS Martin Ratio Rank: 68

LFMD

LFMD Risk / Return Rank: 14
LFMD Sharpe Ratio Rank: 11
LFMD Sortino Ratio Rank: 13
LFMD Omega Ratio Rank: 12
LFMD Calmar Ratio Rank: 12
LFMD Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BVS vs. LFMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bioventus Inc. (BVS) and LifeMD, Inc. (LFMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BVS	LFMD	Difference
Sharpe ratio Return per unit of total volatility	0.52	-0.69	+1.21
Sortino ratio Return per unit of downside risk	1.14	-0.84	+1.97
Omega ratio Gain probability vs. loss probability	1.14	0.88	+0.25
Calmar ratio Return relative to maximum drawdown	0.91	-0.75	+1.66
Martin ratio Return relative to average drawdown	3.41	-0.96	+4.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BVS vs. LFMD - Sharpe Ratio Comparison

The current BVS Sharpe Ratio is 0.52, which is higher than the LFMD Sharpe Ratio of -0.69. The chart below compares the historical Sharpe Ratios of BVS and LFMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BVS	LFMD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.52	-0.69	+1.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.18	-0.22	+0.04
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.11	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.19	0.07	-0.26

Drawdowns

BVS vs. LFMD - Drawdown Comparison

The maximum BVS drawdown since its inception was -95.18%, roughly equal to the maximum LFMD drawdown of -96.24%. Use the drawdown chart below to compare losses from any high point for BVS and LFMD.

Drawdown Indicators

	BVS	LFMD	Difference
Max Drawdown Largest peak-to-trough decline	-95.18%	-96.24%	+1.06%
Max Drawdown (1Y) Largest decline over 1 year	-27.51%	-82.47%	+54.96%
Max Drawdown (3Y) Largest decline over 3 years	-55.22%	-82.47%	+27.25%
Max Drawdown (5Y) Largest decline over 5 years	-95.07%	-92.74%	-2.33%
Max Drawdown (10Y) Largest decline over 10 years	—	-96.24%	—
Current Drawdown Current decline from peak	-57.78%	-84.65%	+26.87%
Average Drawdown Average peak-to-trough decline	-56.39%	-58.53%	+2.14%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.37%	63.91%	-56.54%

Volatility

BVS vs. LFMD - Volatility Comparison

The current volatility for Bioventus Inc. (BVS) is 18.59%, while LifeMD, Inc. (LFMD) has a volatility of 25.85%. This indicates that BVS experiences smaller price fluctuations and is considered to be less risky than LFMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BVS	LFMD	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.59%	25.85%	-7.26%
Volatility (6M) Calculated over the trailing 6-month period	32.52%	63.58%	-31.06%
Volatility (1Y) Calculated over the trailing 1-year period	50.31%	91.89%	-41.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	81.01%	88.02%	-7.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	80.08%	116.08%	-36.00%

Dividends

BVS vs. LFMD - Dividend Comparison

Neither BVS nor LFMD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

BVS vs. LFMD - Profitability Comparison

The chart below illustrates the profitability comparison between Bioventus Inc. and LifeMD, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a gross profit of 90.77M and revenue of 132.09M. Therefore, the gross margin over that period was 68.7%.

LFMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LifeMD, Inc. reported a gross profit of 44.24M and revenue of 50.16M. Therefore, the gross margin over that period was 88.2%.

BVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported an operating income of 8.42M and revenue of 132.09M, resulting in an operating margin of 6.4%.

LFMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LifeMD, Inc. reported an operating income of -8.93M and revenue of 50.16M, resulting in an operating margin of -17.8%.

BVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a net income of 3.11M and revenue of 132.09M, resulting in a net margin of 2.4%.

LFMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LifeMD, Inc. reported a net income of -9.65M and revenue of 50.16M, resulting in a net margin of -19.2%.

Frequently Asked Questions

Can I hold both BVS and LFMD in my portfolio?

BVS and LFMD have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BVS or LFMD?

LFMD has higher volatility (25.85%) compared to BVS (18.59%). In terms of maximum drawdown, BVS dropped -95.18% vs LFMD's -96.24%.

Which has better risk-adjusted returns?

BVS currently has the higher Sharpe Ratio (0.52 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.